等待开盘 10-22 09:30:00 美东时间
+0.090
+0.31%
Mizuho analyst Haendel St. Juste maintains Invitation Homes (NYSE:INVH) with a Outperform and lowers the price target from $32 to $30.
10-21 21:25
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
10-20 10:03
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
10-14 09:56
Evercore ISI Group analyst Steve Sakwa maintains Invitation Homes (NYSE:INVH) with a Outperform and lowers the price target from $35 to $34.
10-13 20:38
今年上半年持续走强的美国独栋出租房租金在7月开始出现明显放缓迹象,显示随着消费者支出压力上升,房东或被迫调整租金策略以适应市场变化
09-23 23:27
U.S. equity REITs saw ~243% rise in their capital raising activities during August to $7.94B from $2.31B in July, data from S&P Global Market Intelligence showed. Below are the notable debt and equity...
09-17 01:56
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
Evercore ISI Group analyst Steve Sakwa maintains Invitation Homes (NYSE:INVH) with a Outperform and lowers the price target from $36 to $35.
09-15 22:03
Invitation Homes (NYSE:INVH) declares $0.29/share quarterly dividend, in line with previous. Forward yield 3.79% Payable Oct. 17; for shareholders of record Sept. 25; ex-div Sept. 25. See INVH Dividen...
09-12 19:05
今日重点评级关注:摩根大通:维持Futu Holdings"超配"评级,目标价从200美元升至270美元;Craig-Hallum:维持英伟达"买入"评级,目标价从195美元升至245美元
08-29 09:47